My goal is to benchmark and innovate spatial profiling assays to molecularly characterize normal and diseased tissues.
I have a strong background in oncology where I have extensively worked with human tumor samples and primary cells to characterize and identify new treatment vulnerabilities. In my current role, I am using diverse tools like spatial transcriptomics, In situ sequencing and spatial epigenomics to characterize an array of tissue types from normal and diseased states.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.